Robb Gary Charles's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Aug 14, 2026
- Accession no.
- 0001193125-26-352428
- Filed
- Aug 14, 2026, 4:31 PM ET
- Trade date
- Aug 12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robb Gary CharlesCIK 0001529655 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | GGiftDisposed | −11,530 | $0.00 | $0 | 13,551 | Direct | |
| Aug 12, 2026 | Common Stock | GGiftAcquired | +3,000 | $0.00 | $0 | 15,571 | Indirect | |
| Aug 12, 2026 | Common Stock | GGiftAcquired | +3,000 | $0.00 | $0 | 15,571 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The power of attorney under which this form was signed is on file with the Commission.